OC
RXO icon

Oppenheimer & Co’s RXO RXO Stock Holding History

Oppenheimer & Co’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Sell
48,030
-1,769
-4% -$39.1K 0.01% 816
2026
Q1 		$728K Buy
49,799
+393
+0.8% +$5.77K 0.01% 1022
2025
Q4 		$624K Buy
49,406
+724
+1% +$10.7K 0.01% 986
2025
Q3 		$749K Buy
48,682
+5,825
+14% +$93.9K 0.01% 1027
2025
Q2 		$674K Buy
42,857
+5,417
+14% +$82.1K 0.01% 1030
2025
Q1 		$715K Buy
37,440
+7,343
+24% +$161K 0.01% 941
2024
Q4 		$718K Buy
30,097
+1,852
+7% +$51.7K 0.01% 930
2024
Q3 		$791K Buy
28,245
+1,520
+6% +$42.9K 0.01% 866
2024
Q2 		$699K Buy
26,725
+5,518
+26% +$115K 0.01% 895
2024
Q1 		$464K Buy
21,207
+2,138
+11% +$45.8K 0.01% 1019
2023
Q4 		$444K Sell
19,069
-17,249
-47% -$347K 0.01% 999
2023
Q3 		$717K Buy
36,318
+2,548
+8% +$50.2K 0.01% 806
2023
Q2 		$766K Sell
33,770
-45,863
-58% -$924K 0.02% 811
2023
Q1 		$1.56M Sell
79,633
-8,386
-10% -$161K 0.03% 528
2022
Q4 		$1.51M Buy
+88,019
New +$1.56M 0.03% 519

Other funds holding RXO

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Oppenheimer & Co's RXO Position: Q2 2026 in Review

Oppenheimer & Co reduced its RXO (RXO) stake by 3.6% in Q2 2026, selling an estimated $39.1K and leaving 48,030 shares worth $1.33M. The position accounts for 0.01% of the portfolio, ranked #816.

Oppenheimer & Co first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.56M in Q1 2023. 305 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Oppenheimer & Co held 48,030 shares of RXO worth $1.33M as of Q2 2026.
  • Oppenheimer & Co sold 1,769 RXO shares in Q2 2026, an estimated $39.1K.
  • RXO made up 0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #816 holding.
  • Oppenheimer & Co first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • Oppenheimer & Co's RXO position peaked at $1.56M in Q1 2023.
  • 305 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.